LMR Partners LLP Invests $3.88 Million in ICU Medical, Inc. (NASDAQ:ICUI)

LMR Partners LLP purchased a new position in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm purchased 21,313 shares of the medical instruments supplier's stock, valued at approximately $3,884,000. LMR Partners LLP owned about 0.09% of ICU Medical as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of ICU Medical by 0.5% during the first quarter. Vanguard Group Inc. now owns 2,452,720 shares of the medical instruments supplier's stock worth $263,226,000 after purchasing an additional 11,991 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in ICU Medical by 21.7% in the second quarter. Dimensional Fund Advisors LP now owns 311,542 shares of the medical instruments supplier's stock valued at $36,996,000 after acquiring an additional 55,588 shares during the period. Silvercrest Asset Management Group LLC increased its holdings in shares of ICU Medical by 109.4% in the first quarter. Silvercrest Asset Management Group LLC now owns 278,436 shares of the medical instruments supplier's stock worth $29,882,000 after acquiring an additional 145,485 shares in the last quarter. WCM Investment Management LLC raised its position in shares of ICU Medical by 1.3% during the third quarter. WCM Investment Management LLC now owns 259,481 shares of the medical instruments supplier's stock worth $45,272,000 after purchasing an additional 3,407 shares during the period. Finally, Bank of New York Mellon Corp lifted its holdings in shares of ICU Medical by 11.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 216,509 shares of the medical instruments supplier's stock valued at $25,710,000 after purchasing an additional 22,310 shares in the last quarter. Institutional investors own 96.10% of the company's stock.

Analyst Upgrades and Downgrades

ICUI has been the topic of several research analyst reports. Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a report on Wednesday, November 13th. StockNews.com lowered shares of ICU Medical from a "buy" rating to a "hold" rating in a research note on Tuesday, November 12th. Jefferies Financial Group assumed coverage on ICU Medical in a research note on Monday, October 14th. They issued a "hold" rating and a $183.00 price target on the stock. Raymond James lifted their target price on ICU Medical from $158.00 to $190.00 and gave the company an "outperform" rating in a research report on Thursday, September 12th. Finally, KeyCorp upped their price target on ICU Medical from $198.00 to $209.00 and gave the stock an "overweight" rating in a research report on Wednesday, November 13th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $173.00.

ICU Medical Stock Down 0.2 %

NASDAQ ICUI traded down $0.28 during trading hours on Tuesday, hitting $169.70. 195,053 shares of the company traded hands, compared to its average volume of 275,017. The stock has a market capitalization of $4.15 billion, a price-to-earnings ratio of -37.33 and a beta of 0.66. ICU Medical, Inc. has a twelve month low of $82.82 and a twelve month high of $196.26. The business's 50-day moving average is $176.52 and its 200-day moving average is $143.81. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29.

Insider Activity

In other news, CEO Vivek Jain sold 12,000 shares of the firm's stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $178.46, for a total transaction of $2,141,520.00. Following the completion of the sale, the chief executive officer now owns 104,593 shares in the company, valued at approximately $18,665,666.78. This trade represents a 10.29 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, VP Daniel Woolson sold 2,502 shares of the company's stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $163.22, for a total transaction of $408,376.44. Following the completion of the transaction, the vice president now owns 13,107 shares in the company, valued at approximately $2,139,324.54. This trade represents a 16.03 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 38,502 shares of company stock valued at $6,573,496. 6.70% of the stock is owned by company insiders.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.